Abstract
Parasitic diseases cause ~500,000 deaths annually and remain a major challenge for therapeutic development. Using a rational design based approach, we developed peptide inhibitors with anti-parasitic activity that were derived from the sequences of parasite scaffold proteins LACK (Leishmania's receptor for activated C-kinase) and TRACK (Trypanosoma receptor for activated C-kinase). We hypothesized that sequences in LACK and TRACK that are conserved in the parasites, but not in the mammalian ortholog, RACK (Receptor for activated C-kinase), may be interaction sites for signaling proteins that are critical for the parasites' viability. One of these peptides exhibited leishmanicidal and trypanocidal activity in culture. Moreover, in infected mice, this peptide was also effective in reducing parasitemia and increasing survival without toxic effects. The identified peptide is a promising new anti-parasitic drug lead, as its unique features may limit toxicity and drug-resistance, thus overcoming central limitations of most anti-parasitic drugs.
Original language | English |
---|---|
Pages (from-to) | 74-84 |
Number of pages | 11 |
Journal | International Journal for Parasitology: Drugs and Drug Resistance |
Volume | 6 |
Issue number | 1 |
DOIs | |
State | Published - 1 Apr 2016 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2016 The Authors.
Funding
This work was supported by the National Institutes of Health ( TW008781-01C-IDEA and SPARK to NQ) and ( AI078505 to DM-R). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The authors declare that there are no conflicts of interest. We thank Dr. Ben Kelly from Louisiana State University for providing antibodies. We thank Dr. Silvia RB Uliana from The University of São Paulo for carrying out initial studies.
Funders | Funder number |
---|---|
National Institutes of Health | TW008781-01C-IDEA, AI078505 |
National Heart, Lung, and Blood Institute | R01HL052141 |
Keywords
- Chagas disease
- LACK
- Leishmaniasis
- Peptide
- Scaffold protein
- TRACK